Match in progress: Double your support for neuropathy research. Donate now!

eNews March 2024

E-news

As the chilly winds of winter give way to the gentle warmth of spring, we find ourselves amidst a season of transformation and renewal. With each new bud and blossom, we are reminded of the potential for growth and progress in the field of neuropathy research. Please join us as we look forward to brighter […]

Read More… from eNews March 2024

Clinical Research Training Scholarship Recipient Announced

CRTS Award winner

The Foundation for Peripheral Neuropathy (FPN) is pleased to announce the 2024 Clinical Research Training Scholarship (CRTS) recipient for peripheral neuropathy (PN), Francesco E. Michelassi, MD, PhD, Neuromuscular Research Fellow, Columbia University Irving Medical Center. Michelassi’s research is fully funded by FPN and will focus on chemotherapy-induced peripheral neuropathy (CIPN), by studying how a chemotherapy […]

Read More… from Clinical Research Training Scholarship Recipient Announced

New PN Biobank Research Discovery!

FPN brochure

In November 2023, a new discovery was made about neuropathic pain in patients suffering from idiopathic peripheral neuropathy. Using data from the Peripheral Neuropathy Research Registry (PNRR), the Foundation for Peripheral Neuropathy’s research consortium completed an important analysis that led to an important discovery. This research is now published in a renowned research journal. Plasma […]

Read More… from New PN Biobank Research Discovery!

FPN Funds IMAGiNe Study for anti-MAG Research

FPN Funds IMAGiNe Study for anti-MAG Research

Through the generosity of our donors, the Foundation for Peripheral Neuropathy (FPN) was able to support the IMAGiNe study with a $165,000 research grant to fund new patient enrollment for anti-MAG neuropathy. $90,000 of these funds were spent in 2022, which resulted in over 150 new patients enrolling in the study. In 2023, an additional $24,750 was spent, […]

Read More… from FPN Funds IMAGiNe Study for anti-MAG Research

eNews January 2024

E-news

Happy New Year! For many, this is a time to reflect on successes from the past year and set intentions for the year ahead. At the Foundation, it’s no different. Our leadership is working on strategic planning, so we can be a stronger organization moving forward. No matter where you are in your PN journey, we […]

Read More… from eNews January 2024

eNews December 2023

E-news

Happiest of holidays to you and yours from the Foundation for Peripheral Neuropathy. We are so grateful for your continued support in our organization, whether you already made your gift to our year end campaign, told someone about us on Giving Tuesday or recently received your PN swag. Thank you and stay safe, cozy and healthy during this season! […]

Read More… from eNews December 2023

eNews November 2023

E-news

November is National Diabetes Awareness Month, a time when communities across the USA seek to bring attention to diabetes – the leading cause of peripheral neuropathy. This year’s focus from the National Institutes of Health is on taking action to prevent diabetes health problems. Check out some resources here and take control of your health. […]

Read More… from eNews November 2023

TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING

Anti-MAG neuropathy

Introduction to Anti-MAG Neuropathy Anti-MAG neuropathy refers to a rare auto-immune associated cause of peripheral neuropathy (PN). In this case, the person’s own immune system (specifically, the IgM monoclonal antibodies) attack nerve cells required for a healthy peripheral nervous system – resulting in a slowly progressive and debilitating condition. Patients often experience loss of mobility, […]

Read More… from TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING

Importance of Peripheral Neuropathy Recognized in Appropriations Act

Importance of Peripheral Neuropathy

Importance of Peripheral Neuropathy: Since 2019, the Foundation for Peripheral Neuropathy has been actively engaged in a campaign to increase federal funding for peripheral neuropathy research. We had an extraordinary breakthrough in fiscal year 2021, when Congress included “peripheral neuropathy” as an eligible condition for research funding from the Department of Defense’s Peer Reviewed Medical Research […]

Read More… from Importance of Peripheral Neuropathy Recognized in Appropriations Act

PN Renewed in Senate Defense Bill

PN renewed in 2024 Defense Appropriations Bill

On July 27, 2023, the Senate Committee on Appropriations approved by a large bipartisan vote the Senate version of the fiscal year 2024 Defense Appropriations Act. As it has in the three previous years (FY21-23), the Committee included “peripheral neuropathy” as an eligible condition for receiving research grants from the Department of Defense’s Peer Reviewed Medical […]

Read More… from PN Renewed in Senate Defense Bill